Your browser is old and is not supported. Upgrade for better security.

Invest in CureLab Veterinary, Inc.

Elenavet® is poised to revolutionize cancer treatment in dogs and cats!

Highlights

1
Using our product line, veterinarians successfully treated 10 out of 11 dogs with breast cancer.
2
Large Market: The US market is actively growing with pet ownership approaching 67% of households.
3
175 million dogs in the USA and Europe and the number is growing. 1 in 4 will develop cancer.
4
199 million cats in US, and Europe and the number is growing. 1 in 5 cats will develop cancer.
5
Elenavet also has strong potential for treating osteoarthritis, IBD, and other inflammatory mediated diseases.
6
80% of dogs over 7 and 90% of cats over 12 develop osteoarthritis.
7
Exclusive licensure of strong intellectual Property & Patents in over 20 countries.
8
Pet ownership provides the owner with many health benefits Elenavet hopes to help them live longer.

Our Team

It has been proven that pet ownership provides their owners with many health benefits including: lowered blood pressure, decreased depression, more exercise, lowered risk of a stroke and heart attack, to name a few. We believe in giving back to humanity and pets, while still enjoying a substantial return on investment, a win/win scenario for all.

Pitch

Forward-looking projections are not guaranteed.

Overview